AstraZeneca’s US$1.5 billion manufacturing plant to create over 800 jobs in Singapore
ASTRAZENECA plans to hire more than 800 employees in Singapore including engineering, technical services and global supply chain roles at ...
Tag: US1.5
Apple to invest up to US$1.5 billion in Globalstar for satellite coverage expansion
APPLE will invest up to US$1.5 billion in Globalstar to fund the expansion of its iPhone communication services, the satellite ...
Indonesia aims for US$1.5 billion restructuring at Krakatau Steel
THE Indonesian government aims to finalise a loan restructuring agreement between the nation’s biggest steelmaker Krakatau Steel and its lenders ...
Nvidia-backed AI startup Sakana hits US$1.5 billion value as Japanese investors pile in
NVIDIA-BACKED Sakana AI was valued at US$1.5 billion a little over a year after its launch, boosted by investments from ...
Hong Kong’s CK Hutchison plans to raise up to US$1.5 billion in dollar bonds: sources
HONG Kong conglomerate CK Hutchison is planning to raise up to US$1.5 billion in a two-tranche US dollar bond deal, ...
Lucid gets US$1.5 billion lifeline before electric suv rollout
LUCID Group will get a cash infusion of as much as US$1.5 billion from one of its biggest investors, an ...
Berkshire sells close to US$1.5 billion of Bank of America shares
WARREN Buffett’s Berkshire Hathaway sold about 34 million shares of Bank of America for US$1.48 billion, according to a public ...
China’s JD.com aims to raise US$1.5 billion in convertible bond deal
CHINESE online retailer JD.com is raising US$1.5 billion via a convertible bond sale, according to the company’s regulatory filings on ...
AstraZeneca to build US$1.5 billion manufacturing plant in Singapore
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that ...
AstraZeneca to build US$1.5 billion manufacturing plant in Singapore
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.